Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Zoltar Insta - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Zoltar Insta

Approved

STANDARD

Zoltar Insta

PharmaEvo (Pvt) Limited🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 63943a869a620a44
Company: PharmaEvo (Pvt) Limited
Type: Standard

Approval Details

Approval Id: 63943a869a620a44
Drug Approval Philippines Name: Zoltar Insta
Product Name: Zoltar Insta
Registration Number: DRP-6220
Brand Name: Zoltar Insta
Generic Name: Omeprazole + Sodium bicarbonate
Dosage Form: Powder for Oral Suspension
Dosage Strength: 20mg/1.680g
Manufacturer: PharmaEvo (Pvt) Limited
Importer: Accesspoint International Trading Inc.
Distributor: Accesspoint International Trading Inc.
Issuance Date: 25 May 2025
Expiry Date: 11 August 2031
Pharmacologic Category: Proton Pump Inhibitor
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

63943a869a620a44

Type

Standard

Back to Philippines FDA Approvals